Literature DB >> 31530682

Assessment of coronary physiology - the evidence and implications.

Noman Ali1, Peysh A Patel2, Christopher J Malkin2.   

Abstract

Use of angiography for the assessment of coronary lesions is limited by its inability to provide information regarding the functional significance of stenoses. A number of studies have demonstrated the presence of ischaemia to be the most important determinant of the benefit associated with coronary revascularisation in stable coronary artery disease. Assessment of intra-coronary physiology can guide percutaneous coronary intervention, and is often used for angiographically borderline stenoses. There is now increasing evidence to suggest that more routine use can improve clinical outcomes. Fractional flow reserve (FFR) is the most established measure of intra-coronary physiology, but is currently under-utilised. The main drawback of FFR is the dependence on a pharmacological infusion to maintain hyperaemia. An alternative technique which measures flow at a specific point in the cardiac cycle (instantaneous wave-free ratio) has been developed which obviates the need for hyperaemia and may replace FFR as the default measure.
© 2019 Royal College of Physicians.

Entities:  

Keywords:  Coronary artery disease; angina; coronary physiology; evidence-based medicine; percutaneous coronary intervention

Year:  2019        PMID: 31530682      PMCID: PMC6771336          DOI: 10.7861/clinmed.2018-0398

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  22 in total

1.  Clinical validation of the resting pressure parameters in the assessment of functionally significant coronary stenosis; results of an independent, blinded comparison with fractional flow reserve.

Authors:  Jin Joo Park; Ricardo Petraco; Chang-Wook Nam; Joon-Hyung Doh; Justin Davies; Javier Escaned; Bon-Kwon Koo
Journal:  Int J Cardiol       Date:  2013-07-26       Impact factor: 4.164

2.  Prospective Assessment of the Diagnostic Accuracy of Instantaneous Wave-Free Ratio to Assess Coronary Stenosis Relevance: Results of ADVISE II International, Multicenter Study (ADenosine Vasodilator Independent Stenosis Evaluation II).

Authors:  Javier Escaned; Mauro Echavarría-Pinto; Hector M Garcia-Garcia; Tim P van de Hoef; Ton de Vries; Prashant Kaul; Ganesh Raveendran; John D Altman; Howard I Kurz; Johannes Brechtken; Mark Tulli; Clemens Von Birgelen; Joel E Schneider; Ahmed A Khashaba; Allen Jeremias; Jim Baucum; Raul Moreno; Martijn Meuwissen; Gregory Mishkel; Robert-Jan van Geuns; Howard Levite; Ramon Lopez-Palop; Marc Mayhew; Patrick W Serruys; Habib Samady; Jan J Piek; Amir Lerman
Journal:  JACC Cardiovasc Interv       Date:  2015-05       Impact factor: 11.195

3.  2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Authors:  Philippe Kolh; Stephan Windecker; Fernando Alfonso; Jean-Philippe Collet; Jochen Cremer; Volkmar Falk; Gerasimos Filippatos; Christian Hamm; Stuart J Head; Peter Jüni; A Pieter Kappetein; Adnan Kastrati; Juhani Knuuti; Ulf Landmesser; Günther Laufer; Franz-Josef Neumann; Dimitrios J Richter; Patrick Schauerte; Miguel Sousa Uva; Giulio G Stefanini; David Paul Taggart; Lucia Torracca; Marco Valgimigli; William Wijns; Adam Witkowski; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Çetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Miguel Sousa Uva; Stephan Achenbach; John Pepper; Anelechi Anyanwu; Lina Badimon; Johann Bauersachs; Andreas Baumbach; Farzin Beygui; Nikolaos Bonaros; Marco De Carlo; Christi Deaton; Dobromir Dobrev; Joel Dunning; Eric Eeckhout; Stephan Gielen; David Hasdai; Paulus Kirchhof; Heyman Luckraz; Heiko Mahrholdt; Gilles Montalescot; Domenico Paparella; Ardawan J Rastan; Marcelo Sanmartin; Paul Sergeant; Sigmund Silber; Juan Tamargo; Jurrien ten Berg; Holger Thiele; Robert-Jan van Geuns; Hans-Otto Wagner; Sven Wassmann; Olaf Wendler; Jose Luis Zamorano
Journal:  Eur J Cardiothorac Surg       Date:  2014-08-29       Impact factor: 4.191

4.  Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation 2 Substudy.

Authors:  Giovanni Ciccarelli; Emanuele Barbato; Gabor G Toth; Brigitta Gahl; Panagiotis Xaplanteris; Stephane Fournier; Anastasios Milkas; Jozef Bartunek; Marc Vanderheyden; Nico Pijls; Pim Tonino; William F Fearon; Peter Jüni; Bernard De Bruyne
Journal:  Circulation       Date:  2017-11-21       Impact factor: 29.690

5.  Effect of Elective Percutaneous Coronary Intervention on Hyperemic Absolute Coronary Blood Flow Volume and Microvascular Resistance.

Authors:  Yoshihisa Kanaji; Tadashi Murai; Taishi Yonetsu; Eisuke Usui; Makoto Araki; Junji Matsuda; Masahiro Hoshino; Masao Yamaguchi; Takayuki Niida; Masahiro Hada; Sadamitsu Ichijyo; Rikuta Hamaya; Yoshinori Kanno; Mitsuaki Isobe; Tsunekazu Kakuta
Journal:  Circ Cardiovasc Interv       Date:  2017-10       Impact factor: 6.546

6.  Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy.

Authors:  Rory Hachamovitch; Alan Rozanski; Leslee J Shaw; Gregg W Stone; Louise E J Thomson; John D Friedman; Sean W Hayes; Ishac Cohen; Guido Germano; Daniel S Berman
Journal:  Eur Heart J       Date:  2011-01-21       Impact factor: 29.983

7.  Coronary pressure measurement to assess the hemodynamic significance of serial stenoses within one coronary artery: validation in humans.

Authors:  N H Pijls; B De Bruyne; G J Bech; F Liistro; G R Heyndrickx; H J Bonnier; J J Koolen
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

8.  Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.

Authors:  Thomas Engstrøm; Henning Kelbæk; Steffen Helqvist; Dan Eik Høfsten; Lene Kløvgaard; Lene Holmvang; Erik Jørgensen; Frants Pedersen; Kari Saunamäki; Peter Clemmensen; Ole De Backer; Jan Ravkilde; Hans-Henrik Tilsted; Anton Boel Villadsen; Jens Aarøe; Svend Eggert Jensen; Bent Raungaard; Lars Køber
Journal:  Lancet       Date:  2015-08-15       Impact factor: 79.321

9.  Real-time use of instantaneous wave-free ratio: results of the ADVISE in-practice: an international, multicenter evaluation of instantaneous wave-free ratio in clinical practice.

Authors:  Ricardo Petraco; Rasha Al-Lamee; Matthias Gotberg; Andrew Sharp; Farrel Hellig; Sukhjinder S Nijjer; Mauro Echavarria-Pinto; Tim P van de Hoef; Sayan Sen; Nobuhiro Tanaka; Eric Van Belle; Waldemar Bojara; Kunihiro Sakoda; Martin Mates; Ciro Indolfi; Salvatore De Rosa; Christian J Vrints; Steven Haine; Hiroyoshi Yokoi; Flavio L Ribichini; Martjin Meuwissen; Hitoshi Matsuo; Luc Janssens; Ueno Katsumi; Carlo Di Mario; Javier Escaned; Jan Piek; Justin E Davies
Journal:  Am Heart J       Date:  2014-07-21       Impact factor: 4.749

Review 10.  Fractional Flow Reserve or Coronary Flow Reserve for the Assessment of Myocardial Perfusion : Implications of FFR as an Imperfect Reference Standard for Myocardial Ischemia.

Authors:  Valérie E Stegehuis; Gilbert W Wijntjens; Jan J Piek; Tim P van de Hoef
Journal:  Curr Cardiol Rep       Date:  2018-07-26       Impact factor: 2.931

View more
  1 in total

1.  Specialisation in medicine - alpha dog or colony ant?

Authors:  Anton Emmanuel
Journal:  Clin Med (Lond)       Date:  2019-09       Impact factor: 5.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.